Reply to Suman Sahoo, Abhishek Pandy, Swarnendu Mandal, Manoj Kumar Das, and Prasant Nayak's Letter to the Editor re: Wei Shen Tan, Aaron Pendergast, Charlotte Ackerman, et al. Adjuvant Intravesical Chemohyperthermia Versus Passive Chemotherapy in Patients with Intermediate-risk Non-muscle-invasive Bladder Cancer (HIVEC-II): A Phase 2, Open-label, Randomised Controlled Trial. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2022.08.003

Autor:	Wei Shen Tan, Connor Mustard, John D. Kelly
Rok vydání:	2022
Předmět:	Urology
Zdroj:	European urology.
ISSN:	1873-7560
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_dedup___::63c5d92edb4f81aae348c13f97c14d25 https://pubmed.ncbi.nlm.nih.gov/36456403 Zobrazit plný text záznamu Full Text from ScienceDirect